Analytics

Equity Analytics

Equity Analytics/NVO

NVO

Novo Nordisk A/S

Healthcare - DK - listed in USD

Novo Nordisk A/S, a leading global healthcare company founded in 1923 and headquartered in Bagsværd, Denmark, develops, manufactures and markets pharmaceutical products and services focused on diabetes care, obesity management, rare blood d…

HQ: Bagsvaerd, CR, Denmarkwww.novonordisk.com

USD41.63+2.41%vs prev. close

Performance

+0.87%

+6.81%

-12.99%

-19.12%

YTD

-20.11%

Valuation

P/E

10.3

EPS TTM

4.06

Dividend yield

4.32%

Size and risk

Market cap

$183.5B

Beta

0.37

Next earnings

Report date

EPS estimate

Revenue estimate

Peer comparison

Novo Nordisk
NVO
Drug Manufacturers - General
Mkt cap (USD bn)
183.5
P/E
10.3
Div yld
4.32%
1W
+0.9%
1M
+6.8%
3M
-13.0%
6M
-11.2%
1Y
-19.1%
YTD
-20.1%

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Novo Nordisk	NVO	Drug Manufacturers - General	183.5	10.3	4.32%	+0.9%	+6.8%	-13.0%	-11.2%	-19.1%	-20.1%

Subscribe to Equity Analytics to compare NVO with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

Ask, then keep asking: it follows the conversation for 30 minutes, grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.

Equity Analytics

NVO

Price history

Next earnings

Peer comparison

Equity Analytics

NVO

Price history

Next earnings

Peer comparison